Zaynich: A New Weapon Against MDR Gram-Negatives

Zaynich: A New Weapon Against MDR Gram-Negatives

In this episode of Diabetic Foot Files, Dr. G explores Zaynich (cefepime + ZD-bactam), a newly FDA-approved IV antibiotic designed to overcome multi-drug resistant gram-negative infections. He explains the drug's dual-target mechanism, its potential role in limb salvage for severe diabetic foot infections, common side effects, dosing, current FDA indications, and when to involve infectious disease specialists. Listeners will learn why this combination may be a game-changer for difficult-to-treat infections, the importance of antibiotic stewardship, and practical considerations for use in wound care and limb salvage scenarios.

Sarcopenia & Diabetic Foot Ulcers: Why Muscle Matters

This episode explains sarcopenia—the progressive loss of skeletal muscle—and how diabetes accelerates it, increasing risk of poor mobility, delayed wound healing, and higher mortality in patients with diabetic foot ulcers. Dr. G reviews the causes (insulin resistance, inflammation, ubiquitin–proteasome activity), clinical signs and tests, and practical treatments including resistance training, protein/leucine supplementation, vitamin D, and tighter glycemic control to preserve muscle and improve outcomes.

To Masquelet or Not to Masquelet? Masquelet Magic: How an Induced Membrane Saves Limbs

This episode explains the Masquelet (induced membrane) technique — a two-stage reconstructive approach where infected bone is removed, an antibiotic-loaded PMMA spacer is placed to control infection and induce a vascular membrane, and weeks later the spacer is removed and the membrane-filled cavity is packed with bone graft to regenerate bone. We cover the science of the induced membrane, antibiotic selection, how diabetes and poor blood flow affect membrane quality, and the technique's role and limitations in diabetic limb salvage.

Forgotten Infection Friday: Ecthyma Gangrenosum — The Rapidly Deadly Black Lesion

This episode explains ecthyma gangrenosum: a rapidly evolving, black necrotic skin lesion most classically caused by Pseudomonas aeruginosa invading blood vessels. It covers the pathophysiology, stages of progression, risk factors (immunocompromise, neutropenia, diabetes), and how it differs from ordinary diabetic foot ulcers. Key takeaways: urgent tissue biopsy and cultures for diagnosis, prompt broad-spectrum IV antibiotics and surgical debridement for source control, and early recognition to prevent sepsis, limb loss, and death.

LIMBWatch Series: Riley Csernica, VP of Product Development at DARCO International: From Napkin to Norm: GO Line ™ Unveiled & The DARCO Story Behind Modern Offloading

On this episode of Limb Watch, Riley Csernica, VP of Product Development at DARCO International, recounts the company’s origin and explains the GO Line ™ innovations — including AirCore™ and PowerPods® — that improve offloading durability, gait stability, and patient adherence in diabetic foot care. She highlights how thoughtful footwear design helps clinicians protect wounds while preserving mobility and work ability, reduces replacement costs, and expands access to effective, long-lasting offloading solutions. If you want to explore the full range of DARCO GO Line ™ solutions—including advanced offloading footwear designed for wound prevention, post-operative recovery, and diabetic foot care—visit the official DARCO International product page. The GO Line ™ features innovative designs like the POGO® Athletic Offloading Sneaker and other clinically engineered systems focused on pressure redistribution, patient mobility, and protection during healing - https://darcointernational.com/go-line/ [https://darcointernational.com/go-line/]